1. Home
  2. RGNT vs HHS Comparison

RGNT vs HHS Comparison

Compare RGNT & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$3.11

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Logo Harte-Hanks Inc.

HHS

Harte-Hanks Inc.

N/A

Current Price

$2.30

Market Cap

21.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
RGNT
HHS
Founded
2004
1923
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
21.2M
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
RGNT
HHS
Price
$3.11
$2.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.4K
3.7K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
97.35
EPS
N/A
N/A
Revenue
N/A
$159,570,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.80
$2.22
52 Week High
$8.35
$5.39

Technical Indicators

Market Signals
Indicator
RGNT
HHS
Relative Strength Index (RSI) 36.17 43.40
Support Level $2.80 $2.33
Resistance Level $3.38 $3.03
Average True Range (ATR) 0.16 0.08
MACD 0.08 -0.01
Stochastic Oscillator 41.66 50.00

Price Performance

Historical Comparison
RGNT
HHS

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

Share on Social Networks: